Hypertriglyceridemia

• FDA label_change · 2022-05-27
  FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)

  FDA notice of a supplemental application for fenofibrate submitted by Cipla USA Inc., likely to update labeling or usage indications.

• FDA label_change · 2021-11-16
  FDA Approved: FENOFIBRATE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for fenofibrate from Apotex Corp., resulting in a label change for the generic product.

• FDA label_change · 2018-05-18
  FDA Approved: FENOFIBRATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  The FDA approved a supplemental application for fenofibrate from Glenmark Pharmaceuticals Inc., USA, resulting in changes to the drug’s labe…

• FDA label_change · 2013-01-18
  FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc., resulting in changes to the drug's…

• FDA label_change · 2009-09-16
  FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)

  The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC, resulting in labeli…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.